Steady-state responses to tone amplitude-modulated at 75 to 110 Hz can be used for frequency-specific objective audiometry. The multiple-stimulus technique allows thresholds to be estimated for eight different stimuli at the same time.
The findings provide insights into the services most valued by families. These findings highlight the importance of eliciting parents' perspectives in designing optimal care models for children and families.
Steady-state responses can be recorded from the human scalp in response to tones that are sinusoidally modulated in amplitude at rates between 60 and 120 Hz. For 60 dB SPL 1000-Hz tones the maximum baseline-to-peak amplitude of about 0.06 microV occurs for modulation rates between 80 and 95 Hz. The phase of the response does not change with modulation depths greater than 25% and the amplitude saturates at modulation depths greater than 50%. The presence or absence of a response can be accurately determined by frequency-domain statistics and the response becomes clearly recognizable at intensities that are 16 +/- 8 dB above behavioral thresholds. With increasing intensity the response increases in amplitude at 1.9 nV/dB until an intensity of 70 dB SPL. As the intensity increases above 70 dB SPL the response increases in amplitude more rapidly at 7.8 nV/dB (at 1000 Hz) and contains significant energy at harmonics of the modulation frequency. This second stage of the intensity function is more prominent for stimuli with lower carrier frequencies (500 more than 1000 more than 2000 Hz) and is attenuated by high-pass masking. These steady-state responses should be helpful in evaluating human auditory physiology and in objective audiometry.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.